课题基金 / 基金详情

Determinants of Regulatory Macrophage Function in Coronary Artery Disease

Determinants of Regulatory Macrophage Function in Coronary Artery Disease
冠状动脉疾病中巨噬细胞调节功能的决定因素
批准号:
10223437
负责人:
Francis Joseph Alenghat
金额:
$8.1万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-08-01 至 2022-07-31

项目摘要

项目成果

Francis Joseph Alenghat的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary / Abstract Inflammation is a major contributor to coronary artery disease (CAD), the process that involves build-up of plaques within the coronary arteries. These plaques result in heart attacks and chronic heart disease due to poor blood supply to the heart muscle, and thus they explain more worldwide morbidity and mortality than any other pathological process. Macrophages are cells of the immune system that are central components of these plaques in CAD. We have discovered critical factors that determine whether macrophages become inflammatory, associated with worse disease, or regulatory, which can reduce disease, and will define whether or not one of these central factors, Skap2, governs the switch from the inflammatory to the regulatory state in plaques. With a clear understanding of what determines macrophage behavior in the plaque, we aspire ultimately to point to new therapies that make macrophages more regulatory—stopping them from driving inflammation—and instead inducing them to heal or stabilize plaques in order to reduce the burden of CAD. This project is innovative and impactful in several ways. First, as opposed to much prior work done on macrophage cell lines or cells derived in vitro, it will define the role of key macrophage molecules in this switch from inflammatory to regulatory function in macrophages isolated directly from the plaque. Second, because translating finding to humans is paramount, it will measure the same regulatory functions and roles of these molecules in human macrophages derived from circulating precursor cells obtained from subjects with varying degrees of CAD, and correlate these findings with plaque composition in humans. Finally, one of the key regulatory functions the project will assess is “efferocytosis”, the clearing of inflammatory debris by macrophages, a process recognized as a potential key determinant of halting inflammation in the plaque and a new treatment target for the future.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.ajpc.2021.100294
发表时间: 2021-12
期刊: American journal of preventive cardiology
影响因子: 4.1
作者: [Pulipati VP, Alenghat FJ]
通讯作者: Alenghat FJ
DOI: 10.1111/ctr.14206
发表时间: 2021-03
期刊: Clinical transplantation
影响因子: 2.1
作者: []
通讯作者:
Determinants of Regulatory Macrophage Function in Coronary Artery Disease
  • 批准号:
    10064521
  • 项目类别:
  • 资助金额:
    $8.1万
  • 财政年份:
    2020
  • 负责人:
    Francis Joseph Alenghat
  • 依托单位:
Integrin-Triggered Signaling and Macrophage Mode Switching in Atherosclerosis
  • 批准号:
    8724990
  • 项目类别:
  • 资助金额:
    $12.05万
  • 财政年份:
    2013
  • 负责人:
    Francis Joseph Alenghat
  • 依托单位:
Integrin-Triggered Signaling and Macrophage Mode Switching in Atherosclerosis
  • 批准号:
    8581225
  • 项目类别:
  • 资助金额:
    $12.05万
  • 财政年份:
    2013
  • 负责人:
    Francis Joseph Alenghat
  • 依托单位:
海外基金